What Medicspot does

Medicspot is a UK-based direct-to-consumer digital health platform founded in 2016 by Dr Zubair Ahmed and headquartered in London, focused on medically supervised weight loss using GLP-1 receptor agonist medications. Its product set centers on Mounjaro (tirzepatide), Wegovy injectable, and Wegovy oral tablets, with a clinical pathway that combines remote GP consultations, prescription issuance, and ongoing coaching support delivered through a subscription model priced from £89 to £329 per month. Medication dispensing is handled through a partnership with The Independent Pharmacy, while clinical governance is overseen by a UK-registered medical team including CMO Dr Abby Hyams.

Operationally, Medicspot runs a telemedicine-first model with prescribing clinicians, certified health coaches, and the regulatory registrations (CQC, GPhC, MHRA) required to prescribe and dispense weight-loss medication in the UK. The company reports a customer base of more than 227,000 and a 4.6/5 Trustpilot rating across 12,354 reviews, indicating a functioning consumer acquisition funnel and high reported customer satisfaction. Underlying technology stack includes standard SaaS tooling such as PostHog for product analytics, with no proprietary AI/ML systems disclosed.

On 30 May 2026 Medicspot was acquired by Doctor Care Anywhere (DCA) for £850,000, folding the asset into a broader virtual-care platform. Prior to that exit the company had raised approximately $3.5M across funding rounds between 2018 and 2020, and operated with a headcount in the 11–50 range. The combination of a large headline customer count against a modest acquisition price and lean headcount indicates material churn between sign-up and active subscription, which is the central financial question for any prospective investor evaluating the asset inside the DCA perimeter.

Name

Medicspot

Legal name

DCA Medicspot Limited

Website

https://medicspot.co.uk

Company type

Private

Founded year

2016

Operating status

Acquired

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Digital Weight Management

NAICS

Offices of Physicians (6211), Offices of Physicians (62111)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

akta.pro secondary industries

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Digital weight management
• GLP-1 medication treatment
• Telehealth weight loss
• Clinical obesity treatment
• Online prescription weight loss

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Subscription Medication and Support Programme: Monthly subscription model where customers pay for access to weight loss medication (Mounjaro, Wegovy, or oral medications) plus comprehensive support services including personal health coaching, WhatsApp community access, behavior change course, nutrition course, and 12 months aftercare support after stopping medication. Pricing varies by medication type and dosage, with first-month discounts available. Each pen/pack provides 4-week supply (injections) or 30-day supply (tablets).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Medicspot is a UK direct-to-consumer digital weight management platform that delivers prescription GLP-1 and dual-agonist weight loss medications (Mounjaro/tirzepatide, Wegovy/semaglutide injections and oral tablets) combined with personal health coaching, a 16-week behaviour change course, WhatsApp peer-support community, monthly clinical reviews, and 12-month aftercare. Customers complete an online clinical assessment reviewed by GPhC-registered independent prescribers at The Independent Pharmacy, who dispense and deliver medication directly to the member's home.

Product overview

Medicspot is a clinician-led digital weight management platform offering prescription GLP-1 and dual-agonist weight loss medications combined with comprehensive behavioural support. The core product portfolio includes Mounjaro (tirzepatide) injectable, Wegovy (semaglutide) injections, and Wegovy oral tablets - each providing clinically-proven weight loss through appetite regulation. These medications are complemented by a suite of support services including personal health coaching, a 16-week behaviour change course, free nutrition course, WhatsApp peer-support community, monthly clinical reviews, and 12-month aftercare support following treatment. All prescribing is conducted by The Independent Pharmacy following individual clinical assessment and review of NHS Summary Care Records. The service operates under NICE and MHRA guidance with all medical information reviewed by UK-registered doctors.

Differentiator

Problem solved

Functional benefit

Products and services

• Mounjaro (Tirzepatide) Weight Loss Injections Weekly injectable GLP-1/GIP dual-agonist weight loss medication available in doses from 2.5mg to 15mg. Prescribed following Medicspot's online clinical assessment for eligible UK adults and dispensed by The Independent Pharmacy with home delivery. Targets adults with BMI 30+ or BMI 27+ with weight-related conditions.
• Wegovy Injections (Semaglutide) Once-weekly semaglutide injection using pre-filled pen. GLP-1 receptor agonist that mimics natural appetite-regulating hormone. Available in doses from 0.25mg to 7.2mg. Up to 20.7% average weight loss in clinical trials. Prescribed and dispensed through The Independent Pharmacy.
• Wegovy Tablets (Oral Semaglutide) Daily oral tablet form of semaglutide for weight loss. Needle-free GLP-1 treatment with doses from 1.5mg to 25mg. Each pack contains 30 tablets (30-day supply). Available by private prescription for eligible adults with BMI 30+ or 27+ with weight-related health conditions.
• Personal Health Coaching One-to-one weekly check-ins with dedicated UKHICA-certified Health Coaches. Provides motivation, side-effect management, and lifestyle change support throughout the treatment journey. Delivered to UK adult Medicspot members as part of the subscription programme.
• Behaviour Change Course 16-week evidence-based programme developed by Dr Adam Abbs and Registered Dietitian Mei Wan, providing proven techniques to help patients develop sustainable healthy lifestyle habits. Included free with Medicspot subscriptions.
• Nutrition Course Free nutrition course included in the treatment plan to help patients transition off weight loss programmes and maintain healthy eating habits long-term.
• Online Clinical Assessment and Prescribing Service Detailed online assessment covering medical history, BMI, weight goals, mental health, eating behaviour, and lifestyle factors. Reviewed by UK-registered GPhC independent prescribers at The Independent Pharmacy before any prescription is issued, with NHS Summary Care Record access and patient GP notification.
• 12-Month Aftercare Support NICE-aligned 12-month structured aftercare support programme for members who have been with Medicspot for at least 4 months. Includes weekly check-ins for the first 3 months after stopping medication, monthly for the following 9 months, plus ongoing behavioural support to sustain weight loss.

Quantifiable outcome

• Up to 26% body weight loss achievable in clinical trials (SURMOUNT-3 for tirzepatide)
• +5 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• The Independent Pharmacy (TIP)coreImplementation/ SI/ Consulting PartnerThe Independent Pharmacy is Medicspot's exclusive prescribing partner, handling all clinical assessments, prescription issuance, and medication dispensing. TIP is CQC-registered for remote clinical prescribing and GPhC-registered for pharmacy dispensing. They conduct independent clinical reviews, access NHS Summary Care Records for safety verification, and notify patients' NHS GPs of prescriptions. TIP also handles all clinical and pharmacy-related complaints.
• Doctor Care Anywhere (DCA)coreStrategic or Co-development PartnerDoctor Care Anywhere acquired Medicspot for a purchase price of £850,000. The acquisition gives DCA immediate presence in the UK's rapidly expanding digital health weight management market and strengthens its direct-to-consumer healthcare offering. This transaction supports DCA's growth strategy by creating cross-selling opportunities across its broader healthcare portfolio.
• Weightmans LLPminorOthersWeightmans, a Liverpool-headquartered law firm, advised Doctor Care Anywhere on its acquisition of Medicspot for £850,000.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Juniper: UK-based subscription telehealth provider focused on medically supervised weight loss using GLP-1 medications combined with coaching. Most direct head-to-head competitor to Medicspot with overlapping UK D2C audience and bundled medication-plus-support proposition.
• Numan: UK digital health subscription platform offering weight-loss treatment alongside men's health services. Directly comparable D2C subscription model with prescribing, coaching, and recurring medication revenue targeting the same UK adult demographic.
• Zava: Established UK/European online clinic offering weight-loss consultations and prescriptions via telehealth. Competes on similar online assessment-to-prescription flow with comparable pricing and regulatory positioning in the UK GLP-1 market.
• Voy: UK digital weight-loss clinic providing GLP-1 prescriptions with clinician oversight and ongoing support. Closely mirrors Medicspot's bundled medication-plus-coaching value proposition in the same UK D2C channel.
• Pharmacy2U: UK online pharmacy and prescription service that has expanded into weight-loss treatment programs. Comparable in dispensing infrastructure and clinical pathway but adds NHS-aligned prescription fulfillment scale.
• Second Nature: UK digital weight-management program combining behavioral coaching with optional medication support. Closely comparable multi-modal weight-loss proposition with an emphasis on behavior change layered over clinical intervention.

Broad incumbents

• LloydsPharmacy Online Doctor: UK high-street pharmacy chain's online consultation service covering weight loss alongside a broad primary care portfolio. Offers overlapping weight-loss prescribing capability but as part of a much wider healthcare offering.
• Hims & Hers: US-listed broad telehealth platform with a fast-growing weight-loss vertical using GLP-1 medications and coaching. Comparable subscription D2C model at scale, though US-focused and operating across many conditions beyond weight.

Others

• The Independent Pharmacy: Medicspot's exclusive prescribing and dispensing partner (CQC/GPhC-registered). Operates as both supplier and adjacent online clinic in its own right; an ecosystem participant rather than a head-to-head competitor.

Emerging players

• Noom: Global digital weight-management platform that has expanded into GLP-1 prescribing via Noom Med. Comparable in combining behavioral coaching with medication pathways, though predominantly US-anchored and an emerging player in the UK.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medicspot_uk
• YouTubeyoutube.com/medicspot
• Facebookfacebook.com/medicspotuk
• LinkedInlinkedin.com/company/medicspot
• Instagraminstagram.com/medicspot
• TikToktiktok.com/@medicspot

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicspot